Transaction in Own Shares

Summary by AI BETAClose X

Bridgepoint Group plc has purchased 70,950 ordinary shares on December 8, 2025, as part of its share buyback program announced on June 2, 2025. The shares were acquired from J.P. Morgan Securities plc at an average price of 281.4497 pence per share, with the highest price paid being 285.00 pence and the lowest 279.00 pence. These purchased shares will be cancelled, which is a common practice that can positively impact shareholder value by reducing the number of outstanding shares.

Disclaimer*

Bridgepoint Group plc
09 December 2025
 

 

Bridgepoint Group plc
("Bridgepoint" or the "Company")

Transaction in own shares

 

Bridgepoint announces that it has purchased from J.P. Morgan Securities plc ("JPM Securities") the following number of ordinary shares of £0.00005 each pursuant to its share buyback programme announced on 2 June 2025.

 

Date of purchase:

8 December 2025

Number of ordinary shares purchased:

70,950

Highest price paid per share (pence):

285.00

Lowest price paid per share (pence):

279.00

Average price paid (pence):

281.4497

 

All shares were purchased from JPM Securities as an on exchange transaction subject to the rules of the London Stock Exchange.

 

The purchased shares will be cancelled.

 

A full breakdown of the individual trades is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/7321K_1-2025-12-8.pdf


 

ENQUIRIES

 

Bridgepoint

 

Analysts and investors

Adam Key

adam.key@bridgepointgroup.com

+44 7833 748010

 

Media

Christian Jones

christian.jones@bridgepointgroup.com

+44 20 7034 3500

 

FGS Global (Public Relations Adviser to Bridgepoint)

James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

bridgepoint-LON@fgsglobal.com

 

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings